Cargando…

Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients

Using a polyclonal antibody monospecific to the c‐erbB‐2 oncogene product, an immunohistochemical study on the expression of c‐erbB‐2 protein was performed in formalin‐fixed, paraffin‐embedded tissue sections from 176 primary breast carcinomas in which amplification of the c‐erbB‐2 gene had been det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuda, Hitoshi, Hirohashi, Setsuo, Shimosato, Yukio, Tanaka, Yuko, Hirota, Teruyuki, Tsugane, Shoichiro, Shiraishi, Masato, Toyoshima, Kumao, Yamamoto, Tadashi, Terada, Masaaki, Sugimura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918040/ https://www.ncbi.nlm.nih.gov/pubmed/1973161 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02571.x

Ejemplares similares

Point Mutation of c‐Ki‐ras Oncogene in Gastric Adenoma and Adenocarcinoma with Tubular Differentiation
por: Kihana, Toshimasa, et al.
Publicado: (1991)

p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade
por: Tsuda, Hitoshi, et al.
Publicado: (1993)

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
por: Zhang, Wandong, et al.
Publicado: (1990)

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
por: Tsuda, Hitoshi, et al.
Publicado: (1989)

Association of Elevated Expression of the c‐erbB‐2 Protein with Spread of Breast Cancer
por: Yamada, Yukinori, et al.
Publicado: (1989)

In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma Cells
por: Mori, Shigeo, et al.
Publicado: (1990)

Expression and Characterization of Kinase‐active v‐erbB Protein Using a Baculovirus Vector System
por: Morishita, Kaoru, et al.
Publicado: (1992)

Adenocarcinoma of the Lung with Selective Metastasis to the Lung: Clinical, Histologic and DNA‐Cytofluorometric Analyses
por: Nomori, Hiroaki, et al.
Publicado: (1992)

A Murine Monoclonal Antibody that Recognizes an Extracellular Domain of the Human c‐erbB‐2 Protooncogene Product
por: Masuko, Takashi, et al.
Publicado: (1989)

Clinicopathological Characteristics of Primary Breast Cancer in Older Geriatric Women: A Study of 39 Japanese Patients over 80 Years Old
por: Morishita, Yukio, et al.
Publicado: (1997)

Construction of Immunoradiometric Assay for Circulating c‐erbB‐2 Protooncogene Product in Advanced Breast Cancer Patients
por: Hosono, Makoto, et al.
Publicado: (1993)

Newly Established Uterine Cervical Carcinoma Cell Line with Co‐amplification of Human Papillomavirus DNA and c‐myc Gene
por: Gotoh, Masahiro, et al.
Publicado: (1991)

Immunohistochemical Detection of Hepatocyte Growth Factor/Scatter Factor in Human Cancerous and Inflammatory Lesions of Various Organs
por: Yoshinaga, Yasuteru, et al.
Publicado: (1993)

Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness
por: Hasebe, Takahiro, et al.
Publicado: (1996)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994)

Quantitative Analysis of ErbB1 and ErbB2 Genes Amplification by a High Performance Liquid Chromatography
por: Rasti, Mozhgan, et al.
Publicado: (2014)

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.
por: Barnes, D. M., et al.
Publicado: (1988)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.
por: Parkes, H. C., et al.
Publicado: (1990)

Clinicopathological Significance of Nuclear Accumulation of Tumor Suppressor Gene p53 Product in Primary Lung Cancer
por: Hiyoshi, Haruhisa, et al.
Publicado: (1992)

Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes
por: Tsuda, Hitoshi, et al.
Publicado: (1992)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
por: Hubbard, A. L., et al.
Publicado: (1994)

Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
por: Kanai, Yae, et al.
Publicado: (1996)

Prognostic Value of p53 Protein Accumulation in Cancer Cell Nuclei in Adenocarcinoma of the Uterine Cervix
por: Tsuda, Hitoshi, et al.
Publicado: (1995)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

A Possible Error in the Interpretation of Gastric Carcinoma
por: Rubio, Carlos, et al.
Publicado: (1991)

Quantitative Distribution of Cluster 1 Small Cell Lung Cancer Antigen in Cancerous and Non‐cancerous Tissues, Cultured Cells and Sera
por: Hirano, Takashi, et al.
Publicado: (1989)

Heterogeneity of Proliferative Activity in Nodule‐in‐Nodule Lesions of Small Hepatocellular Carcinoma
por: Matsuno, Yoshihiro, et al.
Publicado: (1990)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Frequent Development of Murine T‐Cell Lymphomas with TcRα/β(+), CD4(‐)/8 Phenotype after Implantation of Human Inflammatory Breast Cancer Cells in BALB/c Nude Mice
por: Wakasugi, Hiro, et al.
Publicado: (1995)

Quantitation of Gastric Intestinal Metaplasia by Morphometry in Japanese Patients
por: Rubio, Carlos A., et al.
Publicado: (1992)

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
por: Coombs, L. M., et al.
Publicado: (1991)

The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5ptod1ltnsf5gvoj3mlb5nk4i6